It is important to mention that metastatic cancer cells secrete insulin-like growth factor binding protein-2 (IGFBP-2), a biomarker of human metastasis, which makes IGF-1 available in endothelial cells and activates the IGF-1 pathway. This evidence concerns the gene IGF1 and cancer.